Pub. Date : 2000 Dec
PMID : 11249708
2 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | The company launched the drug for the treatment of cutaneous T-cell lymphoma (CTCL), as Targretin capsules, in the US in January 2000 [359023]. | Bexarotene | TSPY like 2 | Homo sapiens |
| 2 | The FDA approved Targretin capsules at the end of December 1999 for once-daily oral treatment of all stages of CTCL in patients refractory to at least one prior systemic therapy, at an initial dose of 300 mg/m2/day. | Bexarotene | TSPY like 2 | Homo sapiens |